Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis — A Literature Review

Research output: Contribution to journal › Review › Research › peer-review

Standard

Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis — A Literature Review. / Poulsen, Valborg Vang; Hadi, Amer; Werge, Mikkel Parsberg; Karstensen, John Gásdal; Novovic, Srdan.

In: Biomolecules, Vol. 14, No. 2, 239, 2024.

Research output: Contribution to journal › Review › Research › peer-review

Harvard

Poulsen, VV, Hadi, A, Werge, MP, Karstensen, JG & Novovic, S 2024, 'Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis — A Literature Review', Biomolecules, vol. 14, no. 2, 239. https://doi.org/10.3390/biom14020239

APA

Poulsen, V. V., Hadi, A., Werge, M. P., Karstensen, J. G., & Novovic, S. (2024). Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis — A Literature Review. Biomolecules, 14(2), [239]. https://doi.org/10.3390/biom14020239

Vancouver

Poulsen VV, Hadi A, Werge MP, Karstensen JG, Novovic S. Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis — A Literature Review. Biomolecules. 2024;14(2). 239. https://doi.org/10.3390/biom14020239

Author

Poulsen, Valborg Vang ; Hadi, Amer ; Werge, Mikkel Parsberg ; Karstensen, John Gásdal ; Novovic, Srdan. / Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis — A Literature Review. In: Biomolecules. 2024 ; Vol. 14, No. 2.

Bibtex

@article{c6ea4119005847b2ab9c9046c44221a0,
title = "Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis — A Literature Review",
abstract = "Chronic pancreatitis (CP) is the end-stage of continuous inflammation and fibrosis in the pancreas evolving from acute- to recurrent acute-, early, and, finally, end-stage CP. Currently, prevention is the only way to reduce disease burden. In this setting, early detection is of great importance. Due to the anatomy and risks associated with direct sampling from pancreatic tissue, most of our information on the human pancreas arises from circulating biomarkers thought to be involved in pancreatic pathophysiology or injury. The present review provides the status of circulating biomarkers involved in the development of and progression to CP.",
keywords = "acute pancreatitis, chronic pancreatitis, fibrosis, inflammation, oxidative stress",
author = "Poulsen, {Valborg Vang} and Amer Hadi and Werge, {Mikkel Parsberg} and Karstensen, {John G{\'a}sdal} and Srdan Novovic",
note = "Publisher Copyright: {\textcopyright} 2024 by the authors.",
year = "2024",
doi = "10.3390/biom14020239",
language = "English",
volume = "14",
journal = "Biomolecules",
issn = "2218-273X",
publisher = "MDPI",
number = "2",

}

RIS

TY - JOUR

T1 - Circulating Biomarkers Involved in the Development of and Progression to Chronic Pancreatitis — A Literature Review

AU - Poulsen, Valborg Vang

AU - Hadi, Amer

AU - Werge, Mikkel Parsberg

AU - Karstensen, John Gásdal

AU - Novovic, Srdan

N1 - Publisher Copyright: © 2024 by the authors.

PY - 2024

Y1 - 2024

N2 - Chronic pancreatitis (CP) is the end-stage of continuous inflammation and fibrosis in the pancreas evolving from acute- to recurrent acute-, early, and, finally, end-stage CP. Currently, prevention is the only way to reduce disease burden. In this setting, early detection is of great importance. Due to the anatomy and risks associated with direct sampling from pancreatic tissue, most of our information on the human pancreas arises from circulating biomarkers thought to be involved in pancreatic pathophysiology or injury. The present review provides the status of circulating biomarkers involved in the development of and progression to CP.

AB - Chronic pancreatitis (CP) is the end-stage of continuous inflammation and fibrosis in the pancreas evolving from acute- to recurrent acute-, early, and, finally, end-stage CP. Currently, prevention is the only way to reduce disease burden. In this setting, early detection is of great importance. Due to the anatomy and risks associated with direct sampling from pancreatic tissue, most of our information on the human pancreas arises from circulating biomarkers thought to be involved in pancreatic pathophysiology or injury. The present review provides the status of circulating biomarkers involved in the development of and progression to CP.

KW - acute pancreatitis

KW - chronic pancreatitis

KW - fibrosis

KW - inflammation

KW - oxidative stress

U2 - 10.3390/biom14020239

DO - 10.3390/biom14020239

M3 - Review

C2 - 38397476

AN - SCOPUS:85185899307

VL - 14

JO - Biomolecules

JF - Biomolecules

SN - 2218-273X

IS - 2

M1 - 239

ER -

ID: 384477028